Traws Pharma Inc logo

Traws Pharma Inc

NAS:TRAW (USA)  
$ 4.58 -0.1616 (-3.41%) 12:08 AM EST
At Loss
P/B:
0
Market Cap:
$ 13.86M
Enterprise V:
$ 8.45M
Volume:
3.92K
Avg Vol (2M):
10.11K
Warning! GuruFocus detected 6 Severe warning signs with TRAW. Try a 7-Day Free Trial to check it out.
Trade In:
Volume:
3.92K
Market Cap $:
13.86M
At Loss
Avg Vol (2M):
10.11K
Enterprise Value $:
8.45M
PB Ratio:
0
Alerts Website SEC Filings Stock PDF
Dataset
Financial Download GuruFocus Premium Icon Manual of Stocksâ„¢

Business Description

Traws Pharma Inc logo
Traws Pharma Inc
NAICS : 325412 SIC : 2834
ISIN : US68232V3069
https://www.onconova.com
12 Penns Trail, Newtown, PA, USA, 18940
Compare
Compare
OCELCALCAPREGOVXFWPAYMBRXMLCTPHGETARAALZNOCSE:NOVO BVRTXREGNASX:CSLSGENXKRX:207940MRNAHKSE:02269XBRU:ARGXBNTX
Traded in other countries / regions
TRAW.USA0T20.Germany
IPO Date
2013-07-25
Description
Traws Pharma Inc is a biopharmaceutical company focused on developing antivirals for influenza, COVID and other respiratory infections and narazaciclib.

Financial Strength

6/10
Name Current Vs Industry Vs History
Cash-To-Debt No Debt
Equity-to-Asset -0.23
Interest Coverage No Debt
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -148.15
Distress
Grey
Safe
Beneish M-Score 108.42
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

6/10
Name Current Vs Industry Vs History
3-Year Revenue Growth Rate -18.6
3-Year EBITDA Growth Rate 23.5
3-Year EPS without NRI Growth Rate 25.3
3-Year FCF Growth Rate 24.6
3-Year Book Growth Rate 0.7
Future 3-5Y EPS without NRI Growth Rate 63.57
Future 3-5Y Total Revenue Growth Rate 13.37

Momentum Rank

2/10
Name Current Vs Industry Vs History
5-Day RSI 47.52
9-Day RSI 43.95
14-Day RSI 42.34
6-1 Month Momentum % -66.55
12-1 Month Momentum % -69.67

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.07
Quick Ratio 1.07
Cash Ratio 0.65
Days Sales Outstanding 708.36

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -19.2

Profitability Rank

1/10
Name Current Vs Industry Vs History
Operating Margin % -10661.06
Net Margin % -62294.25
FCF Margin % -13354.87
ROA % -736.98
ROIC % -2598.58
ROC (Joel Greenblatt) % -130945.65
ROCE % -246.15

GF Value Rank

2/10
Name Current Vs Industry Vs History
PS Ratio 18.39
EV-to-EBIT -0.35
EV-to-Forward-EBIT -0.01
EV-to-EBITDA -0.35
EV-to-Forward-EBITDA -0.01
EV-to-Revenue 37.38
EV-to-Forward-Revenue 1.04
EV-to-FCF -0.28
Price-to-Median-PS-Value 0.78
Earnings Yield (Greenblatt) % -285.71
FCF Yield % -217.81

Financials (Next Earnings Date:2025-02-14 Est.)

TRAW's 30-Y Financials
AAPL
Income Statement Breakdown FY
No Enough Data
AAPL
Balance Sheet Breakdown
No Enough Data
AAPL
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:TRAW

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Traws Pharma Inc Executives

Details

GF Value: $17.01

TRAW

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.226
EPS (TTM) ($) -141.47
Beta 1.89
Volatility % 65.46
14-Day RSI 42.34
14-Day ATR ($) 0.403691
20-Day SMA ($) 4.945285
12-1 Month Momentum % -69.67
52-Week Range ($) 4.06 - 27.5
Shares Outstanding (Mil) 3.03

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Traws Pharma Inc Filings

Filing Date Document Date Form
No Filing Data

Traws Pharma Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Traws Pharma Inc Frequently Asked Questions

What is Traws Pharma Inc(TRAW)'s stock price today?
The current price of TRAW is $4.58. The 52 week high of TRAW is $27.50 and 52 week low is $4.06.
When is next earnings date of Traws Pharma Inc(TRAW)?
The next earnings date of Traws Pharma Inc(TRAW) is 2025-02-14 Est..
Does Traws Pharma Inc(TRAW) pay dividends? If so, how much?
Traws Pharma Inc(TRAW) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1
Research Tools
All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board
Product
Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文
Education
Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation
Company
About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program
Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey
Follow Us
download GuruFocus on Apple store download GuruFocus on Google Play
Disclaimers
GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.
© 2004-2024 GuruFocus.com, LLC. All Rights Reserved.